These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7009403)

  • 21. Benz[c]acridine.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():129-34. PubMed ID: 6586642
    [No Abstract]   [Full Text] [Related]  

  • 22. Benzo[c]phenanthrene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():205-9. PubMed ID: 6586652
    [No Abstract]   [Full Text] [Related]  

  • 23. Fluorene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():365-71. PubMed ID: 6586671
    [No Abstract]   [Full Text] [Related]  

  • 24. Carbazole.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():239-45. PubMed ID: 6586654
    [No Abstract]   [Full Text] [Related]  

  • 25. Anthanthrene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():95-104. PubMed ID: 6586680
    [No Abstract]   [Full Text] [Related]  

  • 26. Vincristine sulphate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():365-84. PubMed ID: 6944267
    [No Abstract]   [Full Text] [Related]  

  • 27. Clofibrate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():39-58. PubMed ID: 7009400
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolism of hydralazine: relevance to drug-induced lupus.
    Hofstra AH
    Drug Metab Rev; 1994; 26(3):485-505. PubMed ID: 7924901
    [No Abstract]   [Full Text] [Related]  

  • 29. Vinblastine sulphate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():349-63. PubMed ID: 6944266
    [No Abstract]   [Full Text] [Related]  

  • 30. Fluoranthene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():355-64. PubMed ID: 6586670
    [No Abstract]   [Full Text] [Related]  

  • 31. Proflavine, proflavine dihydrochloride, proflavine hemisulphate and proflavine monohydrochloride.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():195-209. PubMed ID: 7009393
    [No Abstract]   [Full Text] [Related]  

  • 32. 5-fluorouracil.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():217-35. PubMed ID: 6944260
    [No Abstract]   [Full Text] [Related]  

  • 33. Benz[a]anthracene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():135-45. PubMed ID: 6586643
    [No Abstract]   [Full Text] [Related]  

  • 34. Benzo[j]fluoranthene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():155-61. PubMed ID: 6586645
    [No Abstract]   [Full Text] [Related]  

  • 35. Anthracene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():105-21. PubMed ID: 6586640
    [No Abstract]   [Full Text] [Related]  

  • 36. Dibenz[a,h]anthracene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():299-308. PubMed ID: 6586661
    [No Abstract]   [Full Text] [Related]  

  • 37. Perylene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():411-8. PubMed ID: 6586676
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclophosphamide.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():165-202. PubMed ID: 6944258
    [No Abstract]   [Full Text] [Related]  

  • 39. Methoxsalen.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():101-24. PubMed ID: 6937435
    [No Abstract]   [Full Text] [Related]  

  • 40. [Carcinogenic and mutagenic activities of 3,3'-dichlorobenzidine derivatives--yellow transparent O and K pigments].
    Pylev LN; Vasil'eva LA; Soldatova NG; Gurski T; Galkevich E
    Gig Tr Prof Zabol; 1985 Nov; (11):34-9. PubMed ID: 4085891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.